Works matching IS 09024441 AND DT 2022 AND VI 108 AND IP 4


Results: 11
    1
    2
    3
    4
    5
    6
    7
    8

    Anti‐thymocyte Globulin and Post‐Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen‐A and ‐B mismatched donors.

    Published in:
    European Journal of Haematology, 2022, v. 108, n. 4, p. 288, doi. 10.1111/ejh.13735
    By:
    • Novitzky‐Basso, Igor;
    • Remberger, Mats;
    • Chen, Carol;
    • Ellison, Cynthia;
    • Pasic, Ivan;
    • Lam, Wilson;
    • Law, Arjun;
    • Gerbitz, Armin;
    • Viswabandya, Auro;
    • Lipton, Jeffrey H.;
    • Kim, Dennis D.;
    • Kumar, Rajat;
    • Michelis, Fotios V.;
    • Mattsson, Jonas
    Publication type:
    Article
    9
    10

    Poor outcome after hematopoietic stem cell transplantation of patients with unclassified inherited bone marrow failure syndromes.

    Published in:
    European Journal of Haematology, 2022, v. 108, n. 4, p. 278, doi. 10.1111/ejh.13733
    By:
    • Lim, Yeon Jung;
    • Arbiv, Omri A.;
    • Kalbfleisch, Melanie E.;
    • Klaassen, Robert J.;
    • Fernandez, Conrad;
    • Rayar, Meera;
    • Steele, MacGregor;
    • Lipton, Jeffrey H.;
    • Cuvelier, Geoff;
    • Pastore, Yves D.;
    • Silva, Mariana;
    • Brossard, Josee;
    • Michon, Bruno;
    • Abish, Sharon;
    • Sinha, Roona;
    • Corriveau‐Bourque, Catherine;
    • Breakey, Vicky R.;
    • Tole, Soumitra;
    • Goodyear, Lisa;
    • Sung, Lillian
    Publication type:
    Article
    11

    Issue Information.

    Published in:
    European Journal of Haematology, 2022, v. 108, n. 4, p. 269, doi. 10.1111/ejh.13654
    Publication type:
    Article